The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search

Drugs & Medical Devices Vioxx Research Center News & Warnings

Labeling

in this section: Label Changes | Labeling


Bookmark This Page Print This Page Email This Page

What to Know About Vioxx Labeling

In this section, you will find information on Vioxx and its labeling.

Weitz & Luxenberg is now accepting clients who have been injured by Vioxx. If you have taken Vioxx and have suffered a stroke, heart attack, or other cardiovascular event, please contact Weitz & Luxenberg for a free case evaluation. You can fill out this simple form, call us at 1 (800) 476-6070, or email us at clientrelations@weitzlux.com.

Weitz & Luxenberg is no longer accepting Vioxx cases.


see also:

Label Changes All Vioxx users should know - FDA Approves Label Changes for Vioxx
FDA Label Changes for the drug Vioxx include risks from latest study

Official Documents You can view official Vioxx Documents right here!
A selection of official Vioxx documents regarding Merck and the Recall

News & Warnings The latest news about Vioxx and Merck you must know
Get recent Vioxx News and Warnings from the 2nd Vioxx Lawsuit winners

Free Legal Review:
Name:
Phone:
Email:
Case Description:



For legal help anywhere in the U.S.
Ask a Free Question:
Were you injured?

check for your response [login]
$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims